drugset / Trial / NCT05636579
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical study is to assess the safety of multiple intracameral injections of EO2002 with and without topical Ripasudil.
Timeline
- Start
- 2022-11-08
- Primary completion
- 2025-12-09
- Completion
- 2025-12-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EO2002 | Cell therapy | — | Other |
| Subject | Ripasudil | Small molecule | — | Topical |